Literature DB >> 23832148

p73 - constitutively open for business.

M A Seeliger, U M Moll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23832148      PMCID： PMC3705607          DOI： 10.1038/cdd.2013.56

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  13 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 protects the female germ line during meiotic arrest.

Authors:  Eun-Kyung Suh; Annie Yang; Arminja Kettenbach; Casimir Bamberger; Ala H Michaelis; Zhou Zhu; Julia A Elvin; Roderick T Bronson; Christopher P Crum; Frank McKeon
Journal:  Nature       Date:  2006-11-22       Impact factor: 49.962

3.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  Analysis of the oligomeric state and transactivation potential of TAp73α.

Authors:  L M Luh; S Kehrloesser; G B Deutsch; J Gebel; D Coutandin; B Schäfer; M Agostini; G Melino; V Dötsch
Journal:  Cell Death Differ       Date:  2013-03-29       Impact factor: 15.828

5.  ΔNp63α is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis.

Authors:  William M Keyes; Matteo Pecoraro; Victoria Aranda; Emma Vernersson-Lindahl; Wangzhi Li; Hannes Vogel; Xuecui Guo; Elvin L Garcia; Tatyana V Michurina; Grigori Enikolopov; Senthil K Muthuswamy; Alea A Mills
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

6.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

7.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

Review 8.  Structural biology of the tumor suppressor p53.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

9.  p73 suppresses polyploidy and aneuploidy in the absence of functional p53.

Authors:  Flaminia Talos; Alice Nemajerova; Elsa R Flores; Oleksi Petrenko; Ute M Moll
Journal:  Mol Cell       Date:  2007-08-17       Impact factor: 17.970

10.  DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer.

Authors:  Gregor B Deutsch; Elisabeth M Zielonka; Daniel Coutandin; Tobias A Weber; Birgit Schäfer; Jens Hannewald; Laura M Luh; Florian G Durst; Mohamed Ibrahim; Jan Hoffmann; Frank H Niesen; Aycan Sentürk; Hana Kunkel; Bernd Brutschy; Enrico Schleiff; Stefan Knapp; Amparo Acker-Palmer; Manuel Grez; Frank McKeon; Volker Dötsch
Journal:  Cell       Date:  2011-02-18       Impact factor: 41.582
View more
  3 in total

1.  The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.

Authors:  Camila Hillesheim Horst; Ricardo Titze-de-Almeida; Simoneide Souza Titze-de-Almeida
Journal:  Mol Med Rep       Date:  2017-02-10       Impact factor: 2.952

Review 2.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

Review 3.  miR-34: from bench to bedside.

Authors:  Massimiliano Agostini; Richard A Knight
Journal:  Oncotarget       Date:  2014-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.